Computational Drug Repositioning in Cardiorenal Disease: Opportunities, Challenges, and Approaches

Paul Perco; Matthias Ley; Kinga Kęska‐Izworska; Dorota Wojenska; Enrico Bono; Sebastian G. Walter; Lucas Fillinger; Klaus Kratochwill

doi:10.1002/pmic.202400109

JOURNAL ARTICLE

Computational Drug Repositioning in Cardiorenal Disease: Opportunities, Challenges, and Approaches

Paul Perco Matthias Ley Kinga Kęska‐Izworska Dorota Wojenska Enrico Bono Sebastian G. Walter Lucas Fillinger Klaus Kratochwill

Year: 2025 Journal: PROTEOMICS Vol: 25 (11-12)Pages: e202400109-e202400109 Publisher: Wiley

DOI: 10.1002/pmic.202400109

Get Full-Text PDF Get Analytical Report

Keywords:

Drug repositioning Repurposing Drug Approved drug Medicine Drug development Coronavirus disease 2019 (COVID-19) Disease Intensive care medicine Pharmacology Infectious disease (medical specialty) Internal medicine

Metrics

Cited By

10.04

FWCI (Field Weighted Citation Impact)

108

Refs

0.92

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Computational Drug Discovery Methods

Physical Sciences → Computer Science → Computational Theory and Mathematics

Genomics and Rare Diseases

Life Sciences → Biochemistry, Genetics and Molecular Biology → Genetics

Bioinformatics and Genomic Networks

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

Computational Drug Repositioning in Cardiorenal Disease: Opportunities, Challenges, and Approaches

Metrics

Citation History

Topics

Related Documents

Computational Approaches for Drug Repositioning

Challenges and opportunities of drug repositioning

Computational Approaches for Drug Repositioning and Target Discovery in Alzheimer’s Disease

Computational Drug Repositioning: Current Progress and Challenges

COMPUTATIONAL DRUG REPOSITIONING